| Q47846060 | A broad spectrum Kunitz type serine protease inhibitor secreted by the hookworm Ancylostoma ceylanicum. |
| Q48084570 | A case of mistaken identity--reappraisal of the species of canid and felid hookworms (Ancylostoma) present in Australia and India |
| Q35108111 | A purified Bacillus thuringiensis crystal protein with therapeutic activity against the hookworm parasite Ancylostoma ceylanicum |
| Q34208457 | A review of parasitic zoonoses in a changing Southeast Asia |
| Q40705668 | Ancylostoma caninum anticoagulant peptide-5: immunolocalization and in vitro neutralization of a major hookworm anti-thrombotic |
| Q44265104 | Ancylostoma ceylanicum excretory/secretory protein 1: purification and molecular cloning of a major secretory protein from adult hookworms |
| Q52868229 | Ancylostoma ceylanicum in the hamster: observations on the host-parasite relationship during primary infection |
| Q43218221 | Application of a species-specific PCR-RFLP to identify Ancylostoma eggs directly from canine faeces |
| Q39896384 | CD4 T cells mediate mucosal and systemic immune responses to experimental hookworm infection |
| Q34128889 | Copro-molecular identification of infections with hookworm eggs in rural Lao PDR |
| Q28480978 | Cure of Hookworm Infection with a Cysteine Protease Inhibitor |
| Q58716094 | Cysteine proteases as digestive enzymes in parasitic helminths |
| Q43242970 | Efficacy of a combination product containing pyrantel, febantel and praziquantel (Drontal Plus Flavour, Bayer Animal Health) against experimental infection with the hookworm Ancylostoma ceylanicum in dogs |
| Q52738777 | Efficacy of a spot on combination containing imidacloprid 10% and moxidectin 1% (Advocate(®)/Advantage(®) Multi, Bayer Animal Health) against Ancylostoma ceylanicum in cats |
| Q34163000 | Epidemiological and Genetic Data Supporting the Transmission of Ancylostoma ceylanicum among Human and Domestic Animals |
| Q34875733 | Epidemiology of hookworm infection in Kintampo North Municipality, Ghana: Patterns of malaria coinfection, anemia, and albendazole treatment failure |
| Q43116155 | Experimental infection with Ancylostoma ceylanicum in dogs and efficacy of a spot on combination containing imidacloprid 10% and moxidectin 2.5% (Advocate/Advantage Multi, Bayer Animal Health). |
| Q37390761 | First report of Ancylostoma ceylanicum in wild canids |
| Q33678573 | High prevalence of Ancylostoma ceylanicum hookworm infections in humans, Cambodia, 2012. |
| Q39854346 | Hookworm Infection in Man |
| Q73628509 | Hookworms in dogs of Kuching, Sarawak (north Borneo) |
| Q41275842 | Human enteric infection with Ancylostoma caninum: hookworms reappraised in the light of a "new" zoonosis |
| Q42665343 | Molecular characterization of Ancylostoma inhibitors of coagulation factor Xa. Hookworm anticoagulant activity in vitro predicts parasite bloodfeeding in vivo. |
| Q40153560 | Molecular identification of hookworms in stray and shelter dogs from Guangzhou city, China using ITS sequences |
| Q35910573 | Molecular identification of human hookworm infections in economically disadvantaged communities in Peninsular Malaysia. |
| Q54528682 | PCR-based coprodiagnostic tools reveal dogs as reservoirs of zoonotic ancylostomiasis caused by Ancylostoma ceylanicum in temple communities in Bangkok |
| Q38881583 | Potential Pathogens Reported in Species of the Family Viverridae and Their Implications for Human and Animal Health. |
| Q36112192 | Soil-transmitted helminthiasis in Laos: a community-wide cross-sectional study of humans and dogs in a mass drug administration environment |
| Q39142652 | The prevalence and distribution of gastrointestinal parasites of stray and refuge dogs in four locations in India |
| Q39334876 | The veterinary and public health significance of hookworm in dogs and cats in Australia and the status of A. ceylanicum. |